Introduction
============

Impulsivity is a multidimensional construct generally regarded as a predisposition to make risky decisions without adequate forethought and is well established as a vulnerability factor for drug dependence in humans ([@bib27]) and animals ([@bib2]; [@bib4]; [@bib5]). However, it remains unclear how the trait might have this influence. One view is that impulsivity increases the rewarding effects of some drugs of abuse and consequently intentional or goal-directed drug seeking ([@bib15]), thereby enhancing acquisition of self-administration behavior ([@bib4]; [@bib5]). Consistent with this view, impulsivity has been shown to influence the subjective rewarding effects of nicotine ([@bib20]) and explicit expectancies about nicotine reward ([@bib7]) in humans.

Another view is that impulsivity might accelerate transition to automatic or habitual drug self-administration. Key evidence for this view arises from a rodent paradigm designed to model aspects of "compulsive" drug seeking, the clinical observation of human perseverative drug seeking despite deleterious consequences observed in substance-dependent humans ([@bib26]). In this model, rats respond for cocaine despite receiving an aversive shock. [@bib2] demonstrated that high impulsive rats made a more rapid transition to shock-resistant drug seeking. Furthermore, we have found evidence for impaired goal-directed (and hence more automatic) choice in an outcome devaluation procedure ([@bib16]) in smokers with high levels of motor impulsivity, assessed by the Barrett Impulsiveness Scale (BIS-11: [@bib19]). High levels of impulsivity were also associated with a decoupling of smoking consumption from subjective craving, again suggestive of automatized behavior ([@bib14]).

Supporting both positions, [@bib5] recently observed that two types of impulsive behavior in rats had dissociable effects on the uptake and perseveration of nicotine self-administration in extinction. Specifically, premature responding in the five-choice task predicted higher rates of nicotine self-administration, suggesting hypersensitivity to drug reinforcement. On the other hand, rats showing greater delay discounting showed delayed extinction of nicotine self-administration, perhaps suggestive of inflexible automatized behavior. Likewise, in humans, impulsivity both increases smoking uptake and interferes with quitting ([@bib1]; [@bib12]; [@bib21]).

We have obtained a substantial dataset as a result of several studies of daily smokers and "light or intermittent" smokers ([@bib3]; [@bib23]), recruited predominantly from a student population, in which we had recorded a variety of measures of nicotine use. We considered this group as providing a comprehensive cross-section of the full range of smoking behavior in a young adult population, many of whom were at an early stage of a nicotine addiction. In light of animal studies of the effect of impulsivity on drug seeking ([@bib2]; [@bib4]; [@bib5]) and our previous observations ([@bib14]; Hogarth et al., 2010), we examined the degree to which impulsivity predicted smoking severity and the presence of automatized smoking behaviors. Detailed analysis was performed with respect to the BIS-11 scale and its subscales and specific self-reported symptoms of nicotine dependence using the Diagnostic and Statistical Manual's (*DSM-IV*) criteria for dependence. We predicted that impulsivity would be linked to the constructs of nicotine dependence most indicative of automaticity and the transition to habit rather than with markers of dependence, such as tolerance or withdrawal symptoms. Specifically, the two *DSM* symptoms that we felt most accurately reflected the concept of habit were Numbers 5 and 7, reflecting chain smoking and continued use despite health problems respectively.

Methods
=======

Participants
------------

Data from participants who had participated in studies in which smokers were recruited in our laboratory between 2007 and 2010 were compiled. Each study received ethical approval from the University of Nottingham Ethics Committee, and participants provided signed consent before each study. Participants were only included in the present analysis if they were aged between 18 and 25 years: A very small number of individuals in the entire dataset were 26 years or older and were excluded to create a well-defined age distribution in the range of interest.

Questionnaires
--------------

Data included in our analysis were obtained from self-report questionnaires, which were obtained under similar laboratory circumstances in each individual study. All measures were obtained on the same testing session.

### Diagnostic and Statistical Manual

This questionnaire was made up of the module of questions concerning tobacco use within the alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV: [@bib6]; [@bib13]). Seven criteria could be endorsed, which reflected the experience of a symptom within the participant's lifetime: tolerance (*DSM1*), withdrawal (*DSM2*), increase in use (*DSM3*), difficulty cutting down (*DSM4*), activities to use, obtain, recover (chain smoking: *DSM5*), reducing nonsmoking activities (*DSM6*), and continued use in spite of problems (*DSM7*). Intra-class correlation coefficients of the scale with other measures of dependence and tobacco use are good to excellent (0.6--0.8).

### Cigarette Dependence Scale-5

The cigarette dependence scale ([@bib9]) consists of five questions in which participants rated their level of tobacco addiction, cigarettes smoked per day, time to first cigarette in the morning, expected difficulty quitting, and expected craving following a few hours abstinence. The scales are scored on 5-point scales with total scores varying between 5 and 25. The test--retest reliability and Cronbach's alpha for the scale are \>.8.

### Assessment of Substance Misuse in Adolescence

The assessment of substance misuse in adolescence (ASMA) scale ([@bib28]) assessed whether the individual had ever tried illicit drugs and eight further questions pertaining to drug use when alone, preoccupation with drugs, tolerance, and relief of withdrawal/negative affect (range of scale = 0--9, where *never tried* = 0, *tried* = 1 + number of questions endorsed). The scale has a Cronbach's alpha of .90--.98.

### Barratt Impulsiveness Scale-11

The BIS-11, consisting of 30 questions scored on a 1--4 scale, is a commonly used psychometric tool assessing different types of impulsivity on three main subscales: Attention (Att), Motor (Mot), and Non-planning (NP; [@bib19]). Total BIS-11 score is the sum of the subscale scores.

Data Analysis
-------------

We assessed the association between BIS-11 data (independent measure) and various measures of drug use (dependent measure). The majority of dependent variables were skewed, so Spearman's ρ was used as a nonparametric estimate of the correlation coefficient. Significance of the associations of various measures of nicotine dependence with impulsivity was assessed using a Bonferroni-corrected alpha level. A second analysis was performed in which logistic regression was used to predict the endorsement of symptoms of the *DSM* scale. An uncorrected alpha level of .05 was used for the logistic regression analysis for hypothesis testing.

Results
=======

Demographic Information and Descriptive Statistics
--------------------------------------------------

A dataset of 404 cases were analyzed in the present study. Of the participants, 204 (50.5%) were male and 200 (49.5%) were female. One hundred and eighty-five (45.8) were daily smokers (smoking 7 days per week), and the remaining participants (54.2%) were nondaily smokers. Smoking one (12.6% of the entire sample) or two (13.9% of the entire sample) days per week was most common in the latter group. Within the daily smoking group, 70.3% smoked 5 or more cigarettes a day, while 26.5% smoked 10 or more.

Means and *SD*s of questionnaire data are present in [Table 1](#tbl1){ref-type="table"}. Cronbach's alpha values for the BIS-11 scale were comparable with the expected range of these values (BIS-Total 0.81; BIS-Att 0.70; BIS-Mot 0.65; and BIS-NP 0.60: [@bib25]). Compared with normative values of the BIS-11 ([@bib25]), the population mean of BIS-11 scores was high---just less than 1 *SD* above normative scores.

###### 

Dependent Measures Obtained From Smokers, Assessing Age, Time Smoking, Impulsivity (BIS-11), Measures of Nicotine Dependence (CDS-5 and *DSM*), Number of Cigarettes Smoked Per Day (Number), and Illicit Drug Use (ASMA)

  Variable       *n*   *M*      *SD*
  -------------- ----- -------- -------
  Age            404   20.90    1.45
  Age of onset   404   16.66    2.44
  Years smoked   404   4.37     2.24
  Number         404   6.31     4.52
  *DSM* total    404   4.68     1.52
  CDS-5          404   11.051   4.41
  ASMA           404   2.22     2.064
  BIS-Total      404   70.18    10.73
  BIS-Att        404   18.29    3.89
  BIS-Mot        404   25.66    4.65
  BIS-NP         404   26.23    5.034

*Note*. ASMA = Assessment of Substance Misuse in Adolescence; BIS = Barratt Impulsiveness Scale; CDS = Cigarette Dependence Scale; *DSM* = Diagnostic and Statistical Manual.

Association of BIS-11 With Measures of Dependence
-------------------------------------------------

We observed modest correlations between BIS-11 total score and its subscales with the measures of tobacco use, dependence and craving, and illegal drug use ([Table 2](#tbl2){ref-type="table"}). Although these were generally positive, only a small number reached a Bonferroni-corrected significance level of 0.0025. It was not the case that the relationship between smoking and impulsivity was determined by illegal drug use: A sub group of participants scoring 0 or 1 on the ASMA scale (*n* = 174) showed similar levels of associations between BIS-11 Total impulsivity score and measures of nicotine dependence.

###### 

Measures of Association (Spearman's ρ and accompanying *p* values) Between BIS-11 Impulsivity Scales and Measures of Nicotine Dependence (CDS-5 and *DSM*), Number of Cigarettes Smoked Per Day (Number), Days Smoking Per Week (Days), and Illicit Drug Use (ASMA)

  Questionnaire   BIS-Total ρ, *p* value   BIS-Att ρ, *p* value   BIS-Mot ρ, *p* value   BIS-NP ρ, *p* value
  --------------- ------------------------ ---------------------- ---------------------- ---------------------
  CDS-5           0.13 (.009)\*            −0.011 (.84)           0.13 (.007)\*          0.17 (.001)\*\*
  *DSM* total     0.17 (.001)\*\*          0.034 (.50)            0.22 (\<.001)\*\*      0.12 (.014)\*
  ASMA            0.14 (.004)\*            0.033 (.51)            0.15 (.002)\*\*        0.11 (.025)\*
  Days            0.075 (.14)              −0.035 (.49)           0.094 (.059)           0.11 (.029)\*
  Number          0.096 (.054)             −0.091 (.068)          0.16 (.001)\*\*        0.13 (.010)\*

*Note.* Double-starred coefficients reflect significant associations at a Bonferroni-corrected alpha level (.05/20 = .0025), while single-starred correlations were significant at an uncorrected or false discovery rate--corrected level. ASMA = Assessment of Substance Misuse in Adolescence; BIS = Barratt Impulsiveness Scale; CDS = Cigarette Dependence Scale; *DSM* = Diagnostic and Statistical Manual.

Association of BIS-11 With *DSM* Symptoms
-----------------------------------------

Consistent with our hypotheses, presence of both *DSM5* and *DSM7* symptoms was predicted by variation in total BIS-11 scores using logistic regression. Higher total BIS-11 scores led to an increased likelihood of endorsing the *DSM5* (odds ratio \[*OR*\[ = 1.030, 95% *CI* = 1.010--1.051, *df* = 1, *p* = .0035) and *DSM7* symptom (*OR* = 1.029, 95% *CI* = 1.005--1.053, *df* = 1, *p* = .016). Of the three BIS-11 subscales, the *DSM5* symptom was predicted by the motor subscale (*OR* = 1.098, 95% *CI* = 1.048--1.15, *df* = 1, *p* \< .001) but not the other two subscales. Similarly, the *DSM7* symptom was predicted by motor (*OR* = 1.058, 95% *CI* = 1.003--1.12, *df* = 1, *p* = .038) and non-planning impulsivity (*OR* = 1.050, 95% *CI* = 1.00--1.10, *df* = 1, *p* = .047). None of the associations between total BIS-11 scores and other *DSM* symptoms reached significance at an alpha level of .05 ([Figure 1](#fig1){ref-type="fig"}).

![Odds ratios (*OR*s), which reflect the magnitude of the effect of BIS total score on likelihood of endorsement of a Diagnostic and Statistical Manual (*DSM*) symptom, are displayed. *OR*s are ordered by their magnitude, and stars represent significant regression coefficients. Error bars reflect the 95% *CI* of the observed *OR*. The following symptoms were measured: tolerance (*DSM1*), withdrawal (*DSM2*), increase in use (*DSM3*), difficulty cutting down (*DSM4*), activities to use, obtain, recover (chain smoking: *DSM5*), reducing nonsmoking activities (*DSM6*), and continued use in spite of problems (*DSM7*).](ntrntr114f01_ht){#fig1}

Discussion
==========

In the present study, we sought more clearly to characterize the association between impulsivity and drug use in a large group of individuals with varying levels of tobacco usage recruited from a predominantly student population. First, the population showed a very high level of impulsivity as measured by the Barratt Impulsiveness Scale (BIS-11: [@bib19]; [@bib25]) The high level of impulsivity observed throughout the entire sample in the present study is comparable with previous studies of adult ([@bib18]) and adolescent smokers ([@bib11]; [@bib22]), a variety of different illegal drug user populations ([@bib25]) and somewhat consistent with aspects of personality in chippers ([@bib17]).

Second, consistent with studies in experimental animals ([@bib2]) and our observations with humans smokers ([@bib16]; [@bib14]), BIS-11 scores significantly predicted the presence of two symptoms of tobacco dependence (*DSM5* and *DSM7*), which might be reflective of habitual smoking behavior. *DSM5* was assessed by the endorsement of finding oneself chain smoking or similar. Although chain smoking might reflect a heightened incentive value of cigarettes, we suspect, due to the emphasis of the phrase "find yourself" in the question, that smoking might be automatized in individuals who endorse this symptom. *DSM7* reflects continued smoking despite health problems or other negative consequences, such as depression or anxiety. Again, endorsement of such a symptom is suggestive of an inflexible relationship between consumption and the current value of the drug and accords the observation that impulsivity is associated with perseveration of drug self-administration despite shock punishment in rodents ([@bib2]; [@bib8]). Nevertheless, the negative consequences of drug seeking are manifest within this paradigm (discrete and immediate) somewhat differently to how a smoker might experience them (typically sustained and slower). Both future human and animal work might attempt to identify the range of negative consequences to which drug seeking is insensitive.

However, the notion that impulsivity might also influence the rewarding aspects of nicotine is not ruled out by our findings. In particular, we also observed that BIS-11 scores showed modest but significant associations with a variety of measures of tobacco use and dependence (see also [@bib24]). Furthermore, it is possible that aspects of chain smoking and/or perseverative drug use might also reflect heightened drug reward. Another limitation of the study is that the BIS-11 likely reflects trait impulsivity, which itself has an uncertain relationship with other measures of the construct including inhibitory control or delay discounting, and the degree to which our findings are specific to the BIS-11 deserves further examination.

Summary
=======

We observed that impulsivity was particularly predictive of the endorsement of symptoms of dependence suggestive of the development of automatized or habitual smoking. These data support the view that impulsivity plays a role in hastening the transition to habitual nonintentional control over drug seeking and hence the clinical perseveration of this behavior.
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